Bausch + Lomb Launches EyeGility Preloaded IOL Delivery System in US
Bausch + Lomb has introduced the EyeGility preloaded intraocular lens (IOL) delivery system in the United States, marking another step toward improving efficiency and consistency in cataract surgery. Designed for use with the company’s enVista family of IOLs, the EyeGility system arrives with the lens already loaded into a single-use injector. This eliminates the need for manual lens loading before implantation, simplifying one of the key steps in cataract surgery. While the technology does not change the lens itself, it aims to make the implantation process smoother and more predictable for surgeons and surgical staff.
One of the primary advantages of the EyeGility system is its focus on workflow and ease of use. The injector is engineered for one-handed operation, allowing surgeons to maintain greater control during the procedure. It also features a silicone soft-tipped plunger that helps deliver the lens through a 2.4-millimeter incision while applying a balanced amount of force. Another practical feature is its ability to remain ready for implantation for up to 20 minutes after preparation, providing additional flexibility if surgical timing changes. These design improvements are intended to reduce interruptions and support a more efficient operating room environment.
Preloaded IOL delivery systems have become increasingly popular because they reduce the amount of handling required before lens implantation. By minimizing manual manipulation, these systems can help lower the risk of contamination and reduce the possibility of damage to the lens during preparation. Standardizing the loading process also helps create more consistent surgical outcomes, particularly in high-volume cataract practices where efficiency and reliability are essential. Although experienced surgeons are already proficient with manually loaded systems, preloaded technology offers an opportunity to streamline procedures without compromising precision.
The EyeGility delivery system is currently available with the enVista Aspire IOL, with support for additional lenses in the enVista family, including the enVista Envy, expected to follow. This phased rollout reflects Bausch + Lomb’s broader strategy of expanding its premium cataract surgery portfolio. As patient demand for advanced vision correction continues to grow, manufacturers are increasingly investing not only in innovative lenses but also in the technologies that improve the surgical experience. Devices like EyeGility demonstrate that meaningful innovation can come from refining the tools surgeons use every day, rather than solely developing new implants.
Overall, the launch of the EyeGility preloaded IOL delivery system represents an incremental yet significant advancement in cataract surgery. By simplifying lens preparation, improving ergonomics, and promoting greater consistency during implantation, the system addresses several practical challenges faced in modern ophthalmic surgery. While patients may never see the device itself, they stand to benefit from more efficient procedures and the continued evolution of surgical technology. As cataract surgery remains one of the most commonly performed procedures worldwide, innovations like EyeGility underscore the industry’s ongoing commitment to improving outcomes for both surgeons and patients.
To learn more:
